Marrone bio innovations inc (MBII)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-7,024

-10,141

-16,365

-6,752

-3,917

-5,603

-4,483

-4,870

-5,257

-7,381

-8,530

-7,385

-7,629

-7,810

-7,202

-6,783

-9,276

-11,030

-9,799

-10,985

-11,914

-16,233

-14,400

-10,711

-10,315

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,639

-10,749

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

891

922

524

448

455

463

444

505

478

504

506

513

521

539

546

556

594

894

909

874

833

752

748

593

488

382

238

172

184

Gain on disposal of equipment

9

-

-

-

-

-

-

-

-

2

-369

0

4

0

-77

-53

-5

4

0

39

-4

-34

-124

-85

0

-

-

-

-

Right of use assets amortization

206

203

200

203

199

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation

907

1,780

742

606

558

540

437

382

491

390

555

587

582

644

698

710

617

890

736

1,095

1,090

924

909

1,200

1,522

1,131

581

339

249

Non-cash interest expense

61

64

68

72

73

187

85

111

611

466

400

393

337

339

333

328

329

303

235

132

133

134

118

263

265

247

664

1,937

1,467

Loss on issuance of August 2019 warrants

1,391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

0

0

-5,177

-96

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in estimated fair value of financial instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,550

-3,563

Loss on extinguishment of debt, net

-

-

-

-

-

0

0

0

-2,196

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on extinguishment of debt, related party

-

-

-

-

-

0

0

0

9,183

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of investment securities premiums discounts, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-1

-9

-

-

-

-

Net changes in operating assets and liabilities:
Accounts receivable

4,492

-1,421

-638

-1,358

6,039

-352

-1,650

370

567

1,916

-3,925

-2,279

4,481

1,537

-2,488

-151

2,347

958

-1,562

781

383

-848

-1,365

-1,244

1,460

2,370

-2,224

863

-59

Accounts receivable from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-162

-328

-740

327

903

-267

-1

132

Inventories

-1,072

-683

-148

902

-670

-619

-338

-866

220

494

969

229

-347

77

409

-564

-504

-706

-837

-1,168

-869

-520

-93

-334

874

1,705

4,084

1,561

495

Prepaid Expenses and other assets

281

-577

451

117

336

-393

522

-17

-146

564

318

-596

-142

-17

231

-294

-109

-336

324

147

-277

-403

269

145

298

-507

-2,500

1,075

558

Deferred cost of product revenues

-

-

-

-

-

-

-2

0

-2

120

-467

-585

1,307

1,004

-342

-206

636

448

-449

-342

142

14

-1,241

117

46

-

-

-

-

Accounts payable

3,068

1,588

-1,006

-104

726

-270

401

-1,074

-1,085

1,023

-313

-32

1,627

-811

27

-387

583

940

-2,163

-625

-1,638

2,839

-1,502

-2,407

2,737

-1,339

825

2,058

138

Accrued and other liabilities

-1,500

-3,348

3,771

2,490

310

937

-102

-899

-793

108

1,249

414

828

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

1,336

-136

-379

-1,040

-899

600

828

-605

190

2,548

705

-1,548

1,312

572

577

-1,320

Accrued interest due to related parties

-

-

-

-

-

0

0

0

-1,614

807

-781

798

-820

805

-787

796

-371

-

-

-

-

-

-

-

-

-

-

-

-

Lease Liability

208

156

169

152

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-137

-181

-158

-143

-199

-

-

-

-128

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-1,166

-800

2,307

1,602

-557

64

1,385

981

-577

-690

315

652

-937

-69

246

1,263

2,297

-48

-48

Net cash used in operating activities

-6,292

-4,944

-5,746

-2,999

-7,650

-2,611

-1,864

-5,204

-9,746

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,675

Deferred revenue from related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

168

13

97

183

199

84

254

52

281

-773

-159

33

33

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-7,550

-5,957

-4,811

-3,827

-9,712

-7,495

-8,283

-9,036

-11,360

-8,854

-10,746

-6,453

-9,882

-

-

-

-

Cash flows from investing activities
Payment of future contingent consideration in connection with previous asset purchase

540

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sale of property, plant, equipment

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

7

0

6

0

0

-

-

-

-

Purchases of property, plant and equipment

135

78

33

69

116

84

18

116

362

458

231

77

83

40

76

44

49

157

98

368

1,030

1,673

1,904

4,381

5,044

1,765

863

906

432

Net cash used in investing activities

-673

-182

-6,426

-69

-116

-84

-18

-116

-362

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-432

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

49

-

-

-

-

Maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

249

2,414

11,053

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-83

-40

-76

-44

-49

-157

-98

-368

-1,023

-1,673

-1,649

-1,967

5,960

-

-

-

-

Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

-

-

-

-

-

1

-11

12,676

21,820

0

-35

8,223

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of debt

-

-

-

-

-

0

0

0

2,000

4,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from secured borrowings

11,319

5,371

8,879

8,412

6,714

6,442

5,648

6,234

3,520

8,397

1,680

6,151

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reductions in secured borrowings

6,322

6,699

8,142

9,470

3,511

5,865

6,511

5,476

3,194

8,321

3,350

3,281

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-79

-9,224

Repayment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-66

-65

-66

-64

-65

-64

-179

-95

-97

-107

-134

-70

-67

-

-

-

-

Financing costs

64

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of capital leases

-

-

-

-

-

-

-

-

-

0

68

207

145

272

203

142

204

337

497

657

492

328

526

150

69

67

64

73

25

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

9,139

Exercise of stock options

12

-

-

-

-

-

-

-

-

0

0

0

17

5

10

0

16

-

-

-

-

5

172

277

851

169

70

9

2

Proceeds from employee stock purchase plan

84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exercise of warrants

6,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of debt

196

1,382

207

54

72

64

61

62

67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

10,833

3,479

10,600

-1,047

3,131

346

-844

13,372

24,079

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-108

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

50

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-194

-407

-259

15,206

-253

-347

24,022

-752

-589

-430

1,046

44,752

765

-

-

-

-

Net (decrease) increase in cash and cash equivalents and restricted cash

3,868

-1,647

-1,572

-4,115

-4,635

-2,349

-2,726

8,052

13,971

-3,397

-7,016

8,460

-7,827

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,404

-5,146

11,335

-10,014

-7,999

15,641

-10,156

-12,972

-

-

-

-

-

-

2,446

-8,215

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,349

36,332

-3,157

-

-

-

-

Supplemental disclosure of cash flow information
Cash paid for interest

269

381

290

281

223

74

217

336

2,145

762

2,293

756

2,182

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

713

1,882

-

524

533

536

529

651

581

341

468

358

348

518

Supplemental disclosure of non-cash investing and financing activities
Property, plant and equipment included in accounts payable and accrued liabilities

93

-

0

-5

10

21

-206

36

200

-86

324

-33

40

0

-3

10

14

485

2

-120

132

-45

-585

-1,206

2,040

-

-

-

-

Equipment acquired under capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,586

-

-

-

-

0

188

193

453

1,489

361

179

77

Embedded derivative liability associated with bridge loan

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of debt to equity

-

-

-

-

-

0

0

0

10,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest added to the principal of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

324

671

628

Conversion of bridge loan (convertible note) to equity

-

-

-

-

-

0

0

0

6,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of debt, related party to equity

-

-

-

-

-

0

0

0

35,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of accrued liabilities into equity associated with the granting of restricted stock units

-

-

-

-

-

0

0

0

205

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Embedded derivative liability associated with bridge loan

-

-

-

-

-

0

0

0

573

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-